Help fund the world first ATICUS Network – revolutionising clinical trial access for children battling blood cancer. The network is a pioneering collaboration between 11 leading UK children’s hospitals such as Royal Manchester Children’s and Great Ormond Street, requiring £1million per year to run.
Categories
Beneficiaries
“Most kids are cured, but most is not enough” Prof Rob Wynn, Royal Manchester Children’s Hospital. Blood cancer is the most common type of cancer in children and teens. Blood and bone-marrow transplant is used to try and cure those where chemotherapy fails. Both chemotherapy and transplant are toxic, with side effects during administration, and late effects long after the treatment. Although many children are cured by transplant, many still die of resistant disease or treatment toxicity.
Through funding a network of Research Nurses across 11 children’s hospitals to enable pioneering clinical trials of new drug and cellular therapies to treat children Cure Leukaemia’s funding of a network of Research Nurses enables an adult trial structure in the UK, that has accelerated trials opening with patients receiving new treatments they wouldn’t otherwise have through standard care on the NHS. We want to establish a trials hub and network for children, that currently doesn’t exist.



